Analyst consensus rating
enVVeno Medical Analyst Rating: none
NVNO is rated none by 1 analysts with a $30.00 target. As of 2026-08-26.
Direct answer
enVVeno Medical's consensus rating is none.
1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $30.00.
Forecast evidence checked August 26, 2026.
Get free enVVeno Medical email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $11.47
- Average price target
- $30.00
- High price target
- $30.00
- Low price target
- $30.00
- Low target gap
- +161.6%
- Target upside
- +161.6%
- High target gap
- +161.6%
- Target range width
- 0%
- Consensus rating
- none
- Analysts
- 1
- Evidence date
- August 26, 2026
- Valid through
- September 2, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for enVVeno Medical?
enVVeno Medical has a verified none consensus. The same dataset has an average price target of $30.00.
How far are enVVeno Medical's low and high targets from the recorded price?
The low target implies +161.6%, while the high target implies +161.6%.
How many analysts are included in enVVeno Medical's consensus?
The verified consensus includes 1 analysts.
How is enVVeno Medical's target upside or downside calculated?
The average target of $30.00 is divided by the recorded price of $11.47, then one is subtracted to produce +161.6%. This does not guarantee a future return.
When was enVVeno Medical's analyst forecast verified?
The data was verified on 2026-08-26. The dataset is valid through 2026-09-02.